Starton Therapeutics Phase 2 TROPIC-I Clinical Study will be First to Use Total Control Primary Endpoint in Superiority Study
June 16, 2021 08:00 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., June 16, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company transforming standard of care therapies with...
Starton Therapeutics to Present at 2021 BIO Digital
June 10, 2021 07:00 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., June 10, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event....
Starton Therapeutics Advances STAR-LLD Transdermal Lenalidomide Following Successful Skin Permeation Studies
June 09, 2021 08:00 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary transdermal technology,...
Starton Therapeutics to Participate in the Virtual 20th Annual Needham Healthcare Conference
April 07, 2021 17:00 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company with a continuous delivery platform of approved drugs...
Starton Therapeutics Completes Pre-IND Meeting with FDA: Clearing Path to Phase 1 Clinical Study for STAR-LLD Continuous Infusion
March 22, 2021 08:30 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., March 22, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company with a continuous delivery platform of approved drugs...
Starton Therapeutics and Haisco Pharmaceutical Announce an Exclusive Licensing Agreement to Develop and Commercialize STAR-OLZ for Nausea and Vomiting in China
March 01, 2021 08:00 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J. and CHENGDU, China, March 01, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (Starton), a US-based privately held clinical-stage biopharmaceutical company, and Haisco...
Starton Therapeutics Selects Formulation for Continuous Subcutaneous Lenalidomide Delivery System for CLL Treatment
January 11, 2021 07:40 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in...
Keith Darragh Joins Starton Therapeutics as Chief Financial Officer
September 14, 2020 08:00 ET
|
Starton Therapeutics, Inc.
NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology powering continuous delivery of approved drugs for novel...
Drs. Kenneth Anderson and Asher Chanan-Khan to Join Starton Therapeutics Board of Directors
September 09, 2020 07:45 ET
|
Starton Therapeutics, Inc.
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in novel...
Cidnee Vaykovich Named Starton Therapeutics Chief Operating Officer
August 25, 2020 16:00 ET
|
Starton Therapeutics, Inc.
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs for novel...